世界の心筋虚血治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Myocardial Ischemia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3996
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、心筋虚血治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術、その他）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・心筋虚血治療の市場動向
・企業の競争状況、市場シェア
・心筋虚血治療の種類別市場規模（薬物治療、手術、その他）
・心筋虚血治療の用途別市場規模（病院、診療所、診断センター、その他）
・心筋虚血治療の北米市場規模2016-2027（アメリカ、カナダ）
・心筋虚血治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・心筋虚血治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・心筋虚血治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・心筋虚血治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Novartis、AstraZeneca、Boston Scientific、Johnson & Johnson、Boehringer Ingelheim、Daiichi Sankyo、Merck、Edwards Lifesciences、Bayer、Gene Biotherapeutics、ViroMed）
・結論

Myocardial ischemia is a condition characterized by insufficient blood flow to the heart creating a paucity of oxygen leading to heart attacks. It is also known as cardiac ischemia and the blockage of coronary artery can cause abnormal heart rhythms.
The Americas are the flag-bearer, the region is going to dominate the global market during the forecast period.

Market Analysis and Insights: Global Myocardial Ischemia Treatment Market
The global Myocardial Ischemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Myocardial Ischemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Myocardial Ischemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Myocardial Ischemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Myocardial Ischemia Treatment market.

Global Myocardial Ischemia Treatment Scope and Market Size
Myocardial Ischemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myocardial Ischemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medications
Surgery
Others

Segment by Application
Hospitals
Clinics
Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
AstraZeneca
Boston Scientific
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo
Merck
Edwards Lifesciences
Boston Scientific

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myocardial Ischemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medications
1.2.3 Surgery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myocardial Ischemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Myocardial Ischemia Treatment Market Perspective (2016-2027)
2.2 Myocardial Ischemia Treatment Growth Trends by Regions
2.2.1 Myocardial Ischemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Myocardial Ischemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Myocardial Ischemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Myocardial Ischemia Treatment Industry Dynamic
2.3.1 Myocardial Ischemia Treatment Market Trends
2.3.2 Myocardial Ischemia Treatment Market Drivers
2.3.3 Myocardial Ischemia Treatment Market Challenges
2.3.4 Myocardial Ischemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Myocardial Ischemia Treatment Players by Revenue
3.1.1 Global Top Myocardial Ischemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Myocardial Ischemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Myocardial Ischemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Myocardial Ischemia Treatment Revenue
3.4 Global Myocardial Ischemia Treatment Market Concentration Ratio
3.4.1 Global Myocardial Ischemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myocardial Ischemia Treatment Revenue in 2020
3.5 Myocardial Ischemia Treatment Key Players Head office and Area Served
3.6 Key Players Myocardial Ischemia Treatment Product Solution and Service
3.7 Date of Enter into Myocardial Ischemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Myocardial Ischemia Treatment Breakdown Data by Type
4.1 Global Myocardial Ischemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Myocardial Ischemia Treatment Forecasted Market Size by Type (2022-2027)

5 Myocardial Ischemia Treatment Breakdown Data by Application
5.1 Global Myocardial Ischemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Myocardial Ischemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Myocardial Ischemia Treatment Market Size (2016-2027)
6.2 North America Myocardial Ischemia Treatment Market Size by Type
6.2.1 North America Myocardial Ischemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Myocardial Ischemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Myocardial Ischemia Treatment Market Size by Type (2016-2027)
6.3 North America Myocardial Ischemia Treatment Market Size by Application
6.3.1 North America Myocardial Ischemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Myocardial Ischemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Myocardial Ischemia Treatment Market Size by Application (2016-2027)
6.4 North America Myocardial Ischemia Treatment Market Size by Country
6.4.1 North America Myocardial Ischemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Myocardial Ischemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Myocardial Ischemia Treatment Market Size (2016-2027)
7.2 Europe Myocardial Ischemia Treatment Market Size by Type
7.2.1 Europe Myocardial Ischemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Myocardial Ischemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Myocardial Ischemia Treatment Market Size by Type (2016-2027)
7.3 Europe Myocardial Ischemia Treatment Market Size by Application
7.3.1 Europe Myocardial Ischemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Myocardial Ischemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Myocardial Ischemia Treatment Market Size by Application (2016-2027)
7.4 Europe Myocardial Ischemia Treatment Market Size by Country
7.4.1 Europe Myocardial Ischemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Myocardial Ischemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Myocardial Ischemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Myocardial Ischemia Treatment Market Size by Type
8.2.1 Asia-Pacific Myocardial Ischemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Myocardial Ischemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Myocardial Ischemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Myocardial Ischemia Treatment Market Size by Application
8.3.1 Asia-Pacific Myocardial Ischemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Myocardial Ischemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Myocardial Ischemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Myocardial Ischemia Treatment Market Size by Region
8.4.1 Asia-Pacific Myocardial Ischemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Myocardial Ischemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Myocardial Ischemia Treatment Market Size (2016-2027)
9.2 Latin America Myocardial Ischemia Treatment Market Size by Type
9.2.1 Latin America Myocardial Ischemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Myocardial Ischemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Myocardial Ischemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Myocardial Ischemia Treatment Market Size by Application
9.3.1 Latin America Myocardial Ischemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Myocardial Ischemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Myocardial Ischemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Myocardial Ischemia Treatment Market Size by Country
9.4.1 Latin America Myocardial Ischemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Myocardial Ischemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Myocardial Ischemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Myocardial Ischemia Treatment Market Size by Type
10.2.1 Middle East & Africa Myocardial Ischemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Myocardial Ischemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Myocardial Ischemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Myocardial Ischemia Treatment Market Size by Application
10.3.1 Middle East & Africa Myocardial Ischemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Myocardial Ischemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Myocardial Ischemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Myocardial Ischemia Treatment Market Size by Country
10.4.1 Middle East & Africa Myocardial Ischemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Myocardial Ischemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Myocardial Ischemia Treatment Introduction
11.1.4 Pfizer Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Myocardial Ischemia Treatment Introduction
11.2.4 Novartis Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Myocardial Ischemia Treatment Introduction
11.3.4 AstraZeneca Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Myocardial Ischemia Treatment Introduction
11.4.4 Boston Scientific Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.4.5 Boston Scientific Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Myocardial Ischemia Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Myocardial Ischemia Treatment Introduction
11.6.4 Boehringer Ingelheim Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Details
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Myocardial Ischemia Treatment Introduction
11.7.4 Daiichi Sankyo Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.7.5 Daiichi Sankyo Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Myocardial Ischemia Treatment Introduction
11.8.4 Merck Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Edwards Lifesciences
11.9.1 Edwards Lifesciences Company Details
11.9.2 Edwards Lifesciences Business Overview
11.9.3 Edwards Lifesciences Myocardial Ischemia Treatment Introduction
11.9.4 Edwards Lifesciences Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.9.5 Edwards Lifesciences Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Myocardial Ischemia Treatment Introduction
11.10.4 Bayer Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Gene Biotherapeutics
11.11.1 Gene Biotherapeutics Company Details
11.11.2 Gene Biotherapeutics Business Overview
11.11.3 Gene Biotherapeutics Myocardial Ischemia Treatment Introduction
11.11.4 Gene Biotherapeutics Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.11.5 Gene Biotherapeutics Recent Development
11.12 ViroMed
11.12.1 ViroMed Company Details
11.12.2 ViroMed Business Overview
11.12.3 ViroMed Myocardial Ischemia Treatment Introduction
11.12.4 ViroMed Revenue in Myocardial Ischemia Treatment Business (2016-2021)
11.12.5 ViroMed Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Myocardial Ischemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medications
Table 3. Key Players of Surgery
Table 4. Key Players of Others
Table 5. Global Myocardial Ischemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Myocardial Ischemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Myocardial Ischemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Myocardial Ischemia Treatment Market Share by Regions (2016-2021)
Table 9. Global Myocardial Ischemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Myocardial Ischemia Treatment Market Share by Regions (2022-2027)
Table 11. Myocardial Ischemia Treatment Market Trends
Table 12. Myocardial Ischemia Treatment Market Drivers
Table 13. Myocardial Ischemia Treatment Market Challenges
Table 14. Myocardial Ischemia Treatment Market Restraints
Table 15. Global Myocardial Ischemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Myocardial Ischemia Treatment Market Share by Players (2016-2021)
Table 17. Global Top Myocardial Ischemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myocardial Ischemia Treatment as of 2020)
Table 18. Ranking of Global Top Myocardial Ischemia Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Myocardial Ischemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Myocardial Ischemia Treatment Product Solution and Service
Table 22. Date of Enter into Myocardial Ischemia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Myocardial Ischemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Myocardial Ischemia Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Myocardial Ischemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Myocardial Ischemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Myocardial Ischemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Myocardial Ischemia Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Myocardial Ischemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Myocardial Ischemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Myocardial Ischemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Myocardial Ischemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Myocardial Ischemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Myocardial Ischemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Myocardial Ischemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Myocardial Ischemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Myocardial Ischemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Myocardial Ischemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Myocardial Ischemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Myocardial Ischemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Myocardial Ischemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Myocardial Ischemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Myocardial Ischemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Myocardial Ischemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Myocardial Ischemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Myocardial Ischemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Myocardial Ischemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Myocardial Ischemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Myocardial Ischemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Myocardial Ischemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Myocardial Ischemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Myocardial Ischemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Myocardial Ischemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Myocardial Ischemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Myocardial Ischemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Myocardial Ischemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Myocardial Ischemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Myocardial Ischemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Myocardial Ischemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Myocardial Ischemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Myocardial Ischemia Treatment Product
Table 65. Pfizer Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Myocardial Ischemia Treatment Product
Table 70. Novartis Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Myocardial Ischemia Treatment Product
Table 75. AstraZeneca Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Boston Scientific Company Details
Table 78. Boston Scientific Business Overview
Table 79. Boston Scientific Myocardial Ischemia Treatment Product
Table 80. Boston Scientific Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 81. Boston Scientific Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Myocardial Ischemia Treatment Product
Table 85. Johnson & Johnson Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Myocardial Ischemia Treatment Product
Table 90. Boehringer Ingelheim Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Daiichi Sankyo Company Details
Table 93. Daiichi Sankyo Business Overview
Table 94. Daiichi Sankyo Myocardial Ischemia Treatment Product
Table 95. Daiichi Sankyo Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 96. Daiichi Sankyo Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Edwards Lifesciences Company Details
Table 102. Edwards Lifesciences Business Overview
Table 103. Edwards Lifesciences Myocardial Ischemia Treatment Product
Table 104. Edwards Lifesciences Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 105. Edwards Lifesciences Recent Development
Table 106. Bayer Company Details
Table 107. Bayer Business Overview
Table 108. Bayer Myocardial Ischemia Treatment Product
Table 109. Bayer Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 110. Bayer Recent Development
Table 111. Gene Biotherapeutics Company Details
Table 112. Gene Biotherapeutics Business Overview
Table 113. Gene Biotherapeutics Myocardial Ischemia Treatment Product
Table 114. Gene Biotherapeutics Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 115. Gene Biotherapeutics Recent Development
Table 116. ViroMed Company Details
Table 117. ViroMed Business Overview
Table 118. ViroMed Myocardial Ischemia Treatment Product
Table 119. ViroMed Revenue in Myocardial Ischemia Treatment Business (2016-2021) & (US$ Million)
Table 120. ViroMed Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myocardial Ischemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medications Features
Figure 3. Surgery Features
Figure 4. Others Features
Figure 5. Global Myocardial Ischemia Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Myocardial Ischemia Treatment Report Years Considered
Figure 11. Global Myocardial Ischemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Myocardial Ischemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Myocardial Ischemia Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Myocardial Ischemia Treatment Market Share by Regions (2022-2027)
Figure 15. Global Myocardial Ischemia Treatment Market Share by Players in 2020
Figure 16. Global Top Myocardial Ischemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myocardial Ischemia Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Myocardial Ischemia Treatment Revenue in 2020
Figure 18. Global Myocardial Ischemia Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Myocardial Ischemia Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Myocardial Ischemia Treatment Market Share by Type (2016-2027)
Figure 22. North America Myocardial Ischemia Treatment Market Share by Application (2016-2027)
Figure 23. North America Myocardial Ischemia Treatment Market Share by Country (2016-2027)
Figure 24. United States Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Myocardial Ischemia Treatment Market Share by Type (2016-2027)
Figure 28. Europe Myocardial Ischemia Treatment Market Share by Application (2016-2027)
Figure 29. Europe Myocardial Ischemia Treatment Market Share by Country (2016-2027)
Figure 30. Germany Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Myocardial Ischemia Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Myocardial Ischemia Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Myocardial Ischemia Treatment Market Share by Region (2016-2027)
Figure 40. China Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Myocardial Ischemia Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Myocardial Ischemia Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Myocardial Ischemia Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Myocardial Ischemia Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Myocardial Ischemia Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Myocardial Ischemia Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Myocardial Ischemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 62. Boston Scientific Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 65. Daiichi Sankyo Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 67. Edwards Lifesciences Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 69. Gene Biotherapeutics Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 70. ViroMed Revenue Growth Rate in Myocardial Ischemia Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の脳虚血市場規模・現状・予測（2021年-2027年）

Global Brain Ischemia Market Size, Status and Forecast 2021-2027
QYR2104Z0976 2021年4月 90Pages
QYResearch社発行の本調査資料では、脳虚血のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗凝固療法、抗血小板、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界の心筋血流イメージング（MPI）検査市場規模・現状・予測（2021年-2027年）

Global Myocardial Perfusion Imaging (MPI) Testing Market Size, Status and Forecast 2021-2027
QYR2104Z3997 2021年4月 98Pages
QYResearch社発行の本調査資料では、心筋血流イメージング（MPI）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ストレス心筋血流イメージング（MPI）、安静時心筋血流イメージング（MPI））、用途別市場規模（病院、診療所、外来手術...

世界の虚血再灌流障害市場規模・現状・予測（2021年-2027年）

Global Ischemia Reperfusion Injury Market Size, Status and Forecast 2021-2027
QYR2104Z3284 2021年4月 128Pages
QYResearch社発行の本調査資料では、虚血再灌流障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フェーズ1、フェーズ2、前臨床）、用途別市場規模（心臓傷害、腎臓傷害、腸傷害、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の心筋血行再建術・修復・再生製品・治療市場規模・現状・予測（2021年-2027年）

Global Myocardial Revascularization, Repair, and Regeneration Products and Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z3998 2021年4月 95Pages
QYResearch社発行の本調査資料では、心筋血行再建術・修復・再生製品・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心筋血行再建術、アテローム性動脈硬化症管理技術、現在および新たな心筋修復/再生技術）、用途別市場規模（病院、看護セン...

世界の虚血再灌流傷害治療市場規模・現状・予測（2021年-2027年）

Global Ischemia Reperfusion Injury Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3285 2021年4月 132Pages
QYResearch社発行の本調査資料では、虚血再灌流傷害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ANV-6L15、APP-103、BAY-606583、EP-80317、GS-459679、KN-93、LH-021、その他）、用途...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の心筋血流イメージング（MPI）検査市場規模・現状・予測（2021年-2027年） Myocardial perfusion imaging is an imaging device which work non-invasively to show the blood flow, myocardial perfusion imaging also known as nuclear cardiology test. The main function of this imaging to show the blood flow to muscle of heart or myocardium and to identify the absence or presence of…
世界の脳虚血市場規模・現状・予測（2021年-2027年） Cerebral ischemia or brain ischemia, is a condition that occurs when there isn't enough blood flow to the brain to meet metabolic demand. This leads to limited oxygen supply or cerebral hypoxia and leads to the death of brain tissue, cerebral infarction, orischemic stroke. Market Analysis and Insigh…
世界の虚血再灌流障害市場規模・現状・予測（2021年-2027年） Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrient…
世界の心筋血行再建術・修復・再生製品・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Myocardial Revascularization, Repair, and Regeneration Products and Therapies Market The global Myocardial Revascularization, Repair, and Regeneration Products and Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at…
世界の虚血再灌流傷害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ischemia Reperfusion Injury Therapeutics Market The global Ischemia Reperfusion Injury Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…